Latest Insights on SPR
This Week’s Unusual Options Activity: Three $1 Million Bets to Bank On May 31, 2021 Trading Strategies, True Options Masters The markets are closed for the Memorial Day holiday, but it doesn’t mean there’s not a lot going on. Last week, we saw a ton of unusual options activity. Unusual options activity is traders making big bets outside of earnings plays. It’s common to see big bets around earnings because earnings can be a catalyst […]
Forget ARKK and Bitcoin — Find Bargains Here Instead May 26, 2021 Big Picture. Big Profits., Cryptocurrency, Investment Opportunities Should you buy the dip? With no shortage of pullback candidates, that’s the question on the minds of many investors lately. For instance, Cathie Wood’s ARK Innovation ETF (NYSE: ARKK) has fallen by 31% in just over three months. Nearly $40 billion has been wiped off the exchange-traded fund’s (ETF) assets. Now the carnage has […]
AT & Flee, Plug Power Flies Free & Musk Mauls Bitcoin … Again May 17, 2021 Great Stuff AT & Flee Heard it from a friend who … heard it from a friend who heard it from another AT&T’s (NYSE: ) been messing around. They say AT&T’s got a boyfriend. It was up late this weekend … in talks with Discovery (Nasdaq: ). They’re talking about selling media, and it’s bringing me down. […]
Red Doge Redemption, Crouching Pfizer & Hidden Hydrogen May 13, 2021 Great Stuff Give The Doge A Bone Welcome one and all to the Greatest show in finance! I’m your ringmaster, Mr. Great Stuff … and today is Reader Feedback day. We’ve scoured the Great Stuff inbox for the most intriguing and depraved emails we could find. Today, we answer your questions and share your rants on everything […]
Pfizer’s Pforce Awakens, Apple Strikes Back & CVS’s New Hope May 4, 2021 Great Stuff May The Pfourth Be With You Great Ones, I don’t know if we officially have a winner in the COVID-19 vaccine race, but we certainly have a new front-runner: Pfizer (NYSE: ). I know. I didn’t see it coming either. Apparently, Pfizer makes more than just Viagra. Who knew? OK, I knew. But I didn’t […]





